New Drug Product: Gimoti - MPR
evok-ex991_112.pptx.htm
Spray your symptoms away.
Guide to Getting Your Prescription
Gimoti® (metoclopramide) nasal spray
How to use Gimoti® (metoclopramide) nasal spray
Approval [Rx ONLY]
NASDAQ: EVOK
FDA Approves Gimoti Nasal Spray for Diabetic Gastroparesis - MPR
Gimoti® (metoclopramide) nasal spray pharmacokinetics
Gimoti (Metoclopramide Nasal Spray): Uses, Dosage, Side Effects, Interactions, Warning
FDA Approves Treatment for Recurrent Diabetes Gastroparesis
FDA Approves Evoke's GIMOTI™
New metoclopramide nasal spray (Gimoti) can worsen Parkinson's: Tips on treating GI issues — Parkinson Secrets - Treatment Tips for PWP's & Caregivers -- ParkinsonSecrets.com
Medical Policy
Patheon To Manufacture FDA-Approved Nasal Spray | Contract Pharma
Eversana, Evoke Pharma partner on nasal drug
Evoke Pharma's Gimoti NDA targets female gastroparesis patients with novel delivery approach - BioTuesdays
Gimoti - FDA prescribing information, side effects and uses
Evoke's experience with Thermo wins Patheon commercial Gimoti contract
Gimoti® (metoclopramide) nasal spray
Gimoti - FDA prescribing information, side effects and uses
Evoke Shares Skyrocket On New FDA Market Exclusivity For Gimoti Nasal Spray - Benzinga
Access to Gimoti® (metoclopramide) nasal spray
New Drug Product: Gimoti - MPR
